These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 590287

  • 21. Studies on amelanotic melanoma with the fluorescence method (Falck and Hillarp) and biochemical analysis of 5-S-cysteinyldopa in the tissues.
    Morishima T, Tatsumi F, Fukada E, Watanabe M, Nagashima N, Hanawa S.
    Arch Dermatol Res; 1983; 275(5):329-33. PubMed ID: 6419680
    [Abstract] [Full Text] [Related]

  • 22. Plasma 5-S-cysteinyldopa differentiates patients with primary and metastatic melanoma from patients with dysplastic nevus syndrome and normal subjects.
    Peterson LL, Woodward WR, Fletcher WS, Palmquist M, Tucker MA, Ilias A.
    J Am Acad Dermatol; 1988 Sep; 19(3):509-15. PubMed ID: 3139723
    [Abstract] [Full Text] [Related]

  • 23. [Comparative studies between excretion of 5-S-cysteinyldopa and indole melanogens in urine].
    Beyer C, Fiedler H, Wohlrab W, Wozniak KD.
    Dermatol Monatsschr; 1986 Sep; 172(9):541-4. PubMed ID: 3098590
    [No Abstract] [Full Text] [Related]

  • 24. Plasma 5-S-cysteinyldopa correlates with tumor size in melanoma-bearing mice.
    Hu F, Woodward WR, Peterson LL.
    J Invest Dermatol; 1988 Feb; 90(2):149-51. PubMed ID: 3123557
    [Abstract] [Full Text] [Related]

  • 25. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G, Hansson C, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1978 Feb; 58(3):270-2. PubMed ID: 78645
    [Abstract] [Full Text] [Related]

  • 26. [Melanoma metabolites (proceedings)].
    Rorsman H.
    Lakartidningen; 1978 Dec 06; 75(49):4596-7. PubMed ID: 723347
    [No Abstract] [Full Text] [Related]

  • 27. 5-S-cysteinyldopa in urine and tumors.
    Hara H, Chino K, Kawanami T, Sameshima T, Morishima T.
    J Dermatol; 1992 Nov 06; 19(11):806-8. PubMed ID: 1293167
    [Abstract] [Full Text] [Related]

  • 28. Urinary 5-S-cysteinyldopa in Parkinsonism after DOPA and carbidopa.
    Stewart RM, Miller S, Gunder M.
    Acta Derm Venereol; 1983 Nov 06; 63(2):97-101. PubMed ID: 6189350
    [Abstract] [Full Text] [Related]

  • 29. Urinary excretion of 5-S-cysteinyldopa in patients with primary melanoma or melanoma metastasis.
    Agrup G, Agrup P, Andersson T, Falck B, Hansson J-A, Jacobsson S, Rorsman H, Rosengrem A-M, Rosengren E.
    Acta Derm Venereol; 1975 Nov 06; 55(5):337-41. PubMed ID: 52967
    [Abstract] [Full Text] [Related]

  • 30. The urinary melanogen cysteinyldopa in melanoma and in suntanning: Australian experience.
    Nixon PF.
    Aust N Z J Surg; 1978 Feb 06; 48(1):17-21. PubMed ID: 276342
    [Abstract] [Full Text] [Related]

  • 31. Treatment of malignant melanoma with dacarbazin (DTIC-DOME) with special reference to urinary excretion of 5-S-cysteinyldopa.
    Jönsson PE, Agrup G, Arnbjörnsson E, Hafström L, Rorsman H.
    Cancer; 1980 Jan 15; 45(2):245-8. PubMed ID: 6153150
    [Abstract] [Full Text] [Related]

  • 32. [Treatment of malignant melanoma with DTIC--therapeutic effects determined by 5-S-cysteinyldopa changes in the urine (proceedings)].
    Agrup G, Hafström L, Jönsson PE, Rorsman H.
    Lakartidningen; 1978 Dec 06; 75(49):4599-600. PubMed ID: 364213
    [No Abstract] [Full Text] [Related]

  • 33. Glutathionedopa in malignant melanoma.
    Agrup G, Falck B, Rorsman H, Rosengren AM, Rosengren E.
    Acta Derm Venereol; 1977 Dec 06; 57(3):221-2. PubMed ID: 71825
    [Abstract] [Full Text] [Related]

  • 34. [Correlation of urinary 5-S-cysteinyldopa with repeated remission of melanoma induced by DTIC combination chemotherapy].
    Inoi T, Mojamdar M, Ichihashi M, Mishima Y.
    Nihon Hifuka Gakkai Zasshi; 1982 Sep 06; 92(10):1065-9. PubMed ID: 6821170
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A new approach to the differential diagnosis of human malignant melanomas.
    Rougé F, Aubert C.
    Cancer; 1979 Jul 06; 44(1):199-209. PubMed ID: 455245
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.